Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis

Keyphrases

• Tuberculosis 100%
• Rifabutin 100%
• HIV-related 100%
• Twice Daily 100%
• Rifamycin Resistance 100%
• Treatment Failure 80%
• Clinical Relapse 60%
• CD4 Lymphocyte Count 60%
• Confidence Interval 40%
• Antiretroviral Therapy 40%
• Positive Treatment 40%
• Ethambutol 20%
• Rifampin 20%
• High Risk 20%
• Tuberculosis Treatment 20%
• Adverse Events 20%
• Thrice Weekly 20%
• CD4 Count 20%
• Advanced HIV Disease 20%
• Pyrazinamide 20%
• Direct Supervision 20%
• Tuberculosis Control Programme 20%
• Baseline CD4 20%

Medicine and Dentistry

• Human Immunodeficiency Virus 100%
• Rifamycin 100%
• Rifabutin 100%
• Lymphocyte 60%
• Isoniazid 40%
• Antiretroviral Therapy 40%
• Ethambutol 20%
• Disease 20%
• Cell Count 20%
• Tuberculosis Treatment 20%
• Adverse Event 20%
• Prospective Study 20%
• Rifampicin 20%
• Pyrazinamide 20%

Pharmacology, Toxicology and Pharmaceutical Science

• HIV 100%
• Rifamycin 100%
• Rifabutin 100%
• Isoniazid 40%
• Ethambutol 20%
• Adverse Event 20%
• Disease 20%
• Prospective Study 20%
• Rifampicin 20%
• Pyrazinamide 20%